Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

19.51
Delayed Data
As of Jan 20
 +0.61 / +3.23%
Today’s Change
18.16
Today|||52-Week Range
22.98
+0.77%
Year-to-Date
Is GlaxoSmithKline (GSK) a Great Stock for Value Investors?
Jan 20 / Zacks.com - Paid Partner Content
4 Signs Glaxo's Turnaround Is Taking Hold
Jan 13 / MotleyFool.com - Paid Partner Content
Frontrunning: January 20
Jan 20 / Investing Channel - Paid Partner Content
Merck: Keytruda+Chemo Gets Priority Review for Lung Cancer
Jan 11 / Zacks.com - Paid Partner Content
Flood of News Presents Buying Opportunity
Jan 17 / GuruFocus News - Paid Partner Content
3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock
Jan 10 / MotleyFool.com - Paid Partner Content
Is GlaxoSmithKline's Stock a Bargain After Dropping 4.8% in 2016?
Jan 13 / MotleyFool.com - Paid Partner Content
Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close18.90
Today’s open18.90
Day’s range18.90 - 19.51
Volume615
Average volume (3 months)4,666
Market cap$95.8B
Dividend yield5.21%
Data as of 1:52pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+182.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-3.51%
P/E ratio--
Price/Sales2.71
Price/Book12.53

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$36.5B
Annual profit (last year)$12.9B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs